Caleb was born and raised in Southern Vietnam. He obtained his Chemical and Biomedical Engineering undergraduate degree from the University of Calgary (Alberta, Canada). After graduation, Caleb joined BlueRock Therapeutics/Bayer as a Research Associate in the Process Development team. His work contributes to developing clinical stem cell therapy that can treat intractable disorders such as Parkinson’s disease.
Fascinated by the use of Machine Learning/Artificial Intelligence to understand biology, Caleb pursued a PhD in the UC Berkeley – UCSF Joint PhD Program in Bioengineering. In Adam Abate’s lab at UCSF, Caleb is developing new microfluidic single-cell sequencing tools that enable information linkage across the central dogma. He hopes to apply the technology to studying aging-related neurodegenerative diseases such as Alzheimer’s disease and dementia. Outside of the lab, he enjoys running and kayaking in the sunny Mission Bay neighborhood.